Exousia Bio (LMMY) Return on Sales (2023 - 2025)

Exousia Bio has disclosed Return on Sales across 3 years of filings, most recently posting 0.36% for Q2 2025.

• Return on Sales for Q2 2025 came in at 0.36%, up 37.0% year-over-year; the trailing twelve-month figure through May 2025 was 0.36% (up 38.0% YoY), and the FY2025 annual result was 0.14%, up 16.0% from the prior year.
• Return on Sales came in at 0.36% for Q2 2025 at Exousia Bio, up from 0.18% in the prior quarter.
• In the past five years, Return on Sales ranged from a high of 0.36% in Q2 2025 to a low of 0.01% in Q2 2024.
• The 3-year median for Return on Sales is 0.01% (2023), against an average of 0.08%.
• Across the five-year window, Return on Sales advanced 7 bps in 2024 and soared 37 bps in 2025, its largest moves.
• Exousia Bio's Return on Sales stood at 0.01% in 2023, then surged by 731 bps to 0.06% in 2024, then jumped by 517 bps to 0.36% in 2025.
• The last three Return on Sales figures came in at 0.36% (Q2 2025), 0.18% (Q1 2025), and 0.06% (Q4 2024), per Business Quant data.